Skip to content

Clinical trials

Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 1 Country / region: Canada Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20072
20081
20093
20101
20113
20122
20141
20152
20161
20201
20211
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated4
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
University Health Network, Toronto3
AbbVie2
Celgene2
NCIC Clinical Trials Group2
Astellas Pharma Global Development, Inc.1
Eleah Stringer1
Gemin X1
Genentech, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell25
Lymphoma, Non-Hodgkin10
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Lymphoma, B-Cell, Marginal Zone9
Lymphoma, Follicular9
Lymphoma, Large B-Cell, Diffuse9
Lymphoma, Mantle-Cell9
Recurrence9
Waldenstrom Macroglobulinemia8
Burkitt Lymphoma7

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.